We are a state-of-the art biologics facility supporting cell therapy development and providing extensive research services to companies that are shaping the next generation of cellular immunotherapies. Rubhu Biologics is a comprehensive research organization located in Athens, Georgia. We specialize in the areas of: Cell characterization, Differentiation and Expansion Potency Assays for Cellular Therapy Products Mechanism of Action Studies Immunological studies, Immunogenicity, and Immunotoxicity studies for Cellular Therapy and Biologics Products. With expertise in: T cell and NK cell Therapy Products Pancreatic islet cell therapies Mesenchymal and induced Pluripotent Stem Cells (MSC, iPSCs) therapies Cryopreservation Rubhu Biologics has specific expertise in innovative cell-based therapies and large molecule drug development for the treatment of cancer, autoimmunity, metabolic diseases, and infectious diseases. We have a proven history of developing assays and other associated services that allow cell immunotherapy providers to focus on the task of developing novel life-saving therapies. Rubhu Biologics staff has expertise in the development and validation of bioanalytical assays to evaluate cell-based therapy products. One of the most critical factors in developing new cellular therapy and biologics product today is ensuring that bioanalytical assays are accurate, robust and reproducible. The US Food and Drug Administration (FDA), United States Pharmacopeia (USP), the International Conference on Harmonization (ICH), and European Medicines Agency (EMA), have each recognized the importance of this to the biologics development process and have separately increased qualification and validation requirements in recent years. #celltherapy #genetherapy #ftpharma #cellandgenetherapy #celltherapymanufacturing